Cyclerion Therapeutics is a startup based in the United States.
Based in the United States, Cyclerion Therapeutics is a startup.
Cyclerion Therapeutics is a biopharmaceutical company focused on developing therapies that target soluble guanylate cyclase (sGC) to treat rare and serious diseases associated with cardiovascular and central nervous system disorders.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.